HCA all the acquisitions and ebitda paid

HCA's M&A history is fundamentally different from UHS's. Where UHS makes a few large, transformative deals, HCA runs a high-volume, disciplined, bolt-on machine — smaller deals, right markets, low prices. Here is the full picture.

The Foundational Event: The 2006 KKR/Bain LBO

Before covering acquisitions HCA made as a public company, you need to understand this transaction because it shaped everything that followed.

HCA re-IPO'd in 2011, raising $3.8 billion. The PE sponsors made an extraordinary return — the discipline and cost structure instilled during the private years became the foundation of HCA's public market premium. The critical point: HCA emerged from private equity ownership leaner, more focused, and with a sharper capital allocation framework than it entered.

HCA's Post-IPO Acquisition Strategy: The Pattern

HCA does not make CHS-style $7 billion empire-building bets. Its strategy has been:

1. Acquire hospitals in markets where it already operates — consolidating local market share rather than entering new geographies
2. Buy distressed or non-profit systems at distressed prices — where the seller has no leverage
3. Bolt on adjacent capabilities — nursing education, urgent care, home health — that reduce input costs or expand the care continuum around its hospitals

Almost every deal is sub-$2 billion. Many are sub-$500 million. The EBITDA multiples are consistently below where HCA itself trades.

The Major Acquisitions

1. Mission Health (North Carolina) — 2019

The 8.86x EBITDA multiple was consistent with where HCA itself traded at the time, but the effective multiple was likely much lower once synergies were factored in. The 0.83x revenue multiple was well below the public peer average of 1.46x at the time — meaning on a revenue basis alone the deal was highly accretive to HCA, which itself traded at 1.78x revenue. VMG Health

Mission was a non-profit with a captive regional monopoly — exactly the type of asset HCA prefers. Post-acquisition, HCA applied its revenue cycle, labor management, and contracting advantages to a system that had never had them. The deal has been financially very successful, though it generated significant controversy: the North Carolina attorney general later accused HCA of breaching the terms of the deal by reducing emergency and oncology service levels, receiving more than 500 complaints about the Mission Health facilities. Modern Healthcare

2. Galen College of Nursing — 2020

This is a classic HCA lateral move. Rather than paying market rates for travel nurses — which was destroying margins across the sector during COVID — HCA bought its own nursing school. HCA paid $400 million for a majority 80% stake in Galen, creating what management called "the largest academic practice partnership in all of US healthcare." Galen graduates are funnelled directly into HCA hospitals, reducing dependence on expensive agency staffing. This is textbook vertical integration — solving an input cost problem through ownership rather than market purchasing. Hcahealthcare

3. Brookdale Home Health JV — 2021

HCA paid approximately 1.1x Brookdale's 2019 sales, below what analysts considered fair value for home health assets at the time, reflecting Brookdale's weakened negotiating position. HCA then rationalized the portfolio almost immediately, selling 47 non-strategic locations to LHC Group and retaining only those home health agencies adjacent to its existing hospital markets. A neat example of buying a portfolio, keeping what fits, and flipping the rest — essentially getting the strategic assets at a discount. Home Health Care News

4. MD Now Urgent Care — 2022

Florida is HCA's single largest market. MD Now gave HCA a network of outpatient touchpoints to capture patients before they ever reach a competitor's ER — a classic market density play. Urgent care multiples in 2022 were approximately 10–14x EBITDA, but HCA likely paid at the lower end given the Florida-specific nature of the portfolio.

5. Catholic Medical Center (New Hampshire) — 2025

CMC was on the brink of bankruptcy when HCA acquired it, projecting a $41.5 million loss, with credit agencies downgrading it and insufficient cash to replace a crumbling power plant that "would render the hospital wholly inoperable" if it failed. Yahoo Finance

HCA paid $110M for a distressed asset that regulators needed saved — giving HCA enormous leverage in negotiations. The real cost is the $200M capital commitment, making total outlay ~$310M for a 330-bed hospital in a market (Manchester, NH) where HCA already operated three other facilities. On a per-bed basis ($940K/bed), this is well below greenfield construction costs of $1.5–2M per bed. Once HCA applies its operational playbook to a turnaround, the returns on distressed acquisitions like this are typically very high.

6. College of Health Care Professions — 2026 (recent)

HCA and CHCP had already been collaborating on a 12-week Medical Assistant training program for HCA's urgent care centers in Texas before the acquisition. This follows the Galen template exactly — first partner, then acquire once the strategic fit is proven. Investing.com

HCA's Organic Capital Deployment: The Bigger Story

Here is the insight most acquisition analyses miss about HCA: its most important capital allocation is not acquisitions — it's organic reinvestment and buybacks.

HCA spends approximately $5 billion per year in capital expenditures on its existing hospital network — building new towers, adding beds, upgrading clinical programs, expanding surgery centers. This organic reinvestment is where HCA has generated its extraordinary ROIC of 17–18%, far above what acquisitions alone could produce.

And when it isn't reinvesting, it is buying back its own stock aggressively. In 2022 alone, HCA bought back $7 billion or 30 million shares. Since 2019, the share count has declined from ~350M shares to ~260M — a 26% reduction — which mechanically drives EPS growth even when revenue growth is modest. Nhsforsale

Summary: The HCA Acquisition Philosophy vs. Peers

The HCA pattern reveals something important about what separates great capital allocators from average ones: it's not the multiple paid, it's the quality of the asset and the ability to improve it post-close. HCA consistently buys non-profits with poor operational discipline and applies its scale advantages — revenue cycle, labor, contracting — to extract synergies that justify the price. The multiples paid (8–10x) look similar to peers, but the returns generated are materially higher because of superior post-acquisition execution.